Quidel Corp (QDEL)

43.54
0.01 0.02
NASDAQ : Health Care
Prev Close 43.55
Open 43.81
Day Low/High 43.45 / 44.35
52 Wk Low/High 13.21 / 23.37
Volume 399.22K
Avg Volume 402.00K
Exchange NASDAQ
Shares Outstanding 33.44M
Market Cap 1.37B
EPS -0.40
P/E Ratio 339.09
Div & Yield N.A. (N.A)

Latest News

Quidel To Present At The 37th Annual Canaccord Genuity Growth Conference

Quidel To Present At The 37th Annual Canaccord Genuity Growth Conference

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the 37 th Annual Canaccord...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BA, CAI, CNHI, FFWM, FSV, NEP, NOW, TGI, TRK, TSU, WPG Downgrades: AAT, BLMN, FBR, GSK, HZO, QDEL, VRTX Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Quidel Reports Second Quarter 2017 Financial Results

Quidel Reports Second Quarter 2017 Financial Results

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the second quarter ended...

Abbott CEO: Another Alere-Related Divestiture Coming Soon

Abbott CEO: Another Alere-Related Divestiture Coming Soon

Abbott CEO Miles White said on an earnings call the company will make one more asset sale as part of efforts to gain regulatory approval for the Abbott-Alere deal.

Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings

Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings

Abbott will report second-quarter numbers on Thursday as it completes the Alere deal. $ABT $ALR

Quidel Diversifies With Alere's Triage Assets

Quidel Diversifies With Alere's Triage Assets

The Triage assets are being divested in order to secure antitrust approvals for Abbott Laboratories' purchase of Alere.

Action Was Under the Surface in Monday's Market

Action Was Under the Surface in Monday's Market

Monday's index action was quiet, but traders still found issues to play.

Quidel Announces Definitive Agreement To Acquire Alere Triage® Assets

Quidel Announces Definitive Agreement To Acquire Alere Triage® Assets

Quidel Corporation (NASDAQ: QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has entered into definitive...

Quidel To Hold Second Quarter 2017 Financial Results Conference Call On July 26, 2017

Quidel To Hold Second Quarter 2017 Financial Results Conference Call On July 26, 2017

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report second quarter 2017 financial results after market close on...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: MYOK, NTLA, QDEL, RM Downgrades: FANG Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Quidel Receives FDA Clearance And CLIA Waiver For Its Point-of-Care Sofia® 2 Instrument For Use With Sofia Respiratory Syncytial Virus (RSV) Assay

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today it has received 510(k) clearance and Clinical Laboratory...

Quidel's Sofia® 2 Point-of-Care Immunoassay Analyzer Receives Multiple Awards From Good Design Australia®'s 2017 Good Design Awards®

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that its Sofia 2 point-of-care immunoassay analyzer has...

Quidel Receives The CE Mark For Its Thyretain® TBI Reporter BioAssay

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today it has received the CE Mark for Quidel's Thyretain®...

Quidel Receives FDA Clearance And CLIA Waiver For Its Point-of-Care Sofia® 2 Immunoassay Analyzer For Use With Sofia Influenza A+B Assay

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today it has received 510(k) clearance and Clinical Laboratory...

Quidel Receives PMDA Approval For Its Point-of-Care Sofia® Influenza A+B Assay

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today it has received approval from Japan's Pharmaceuticals...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ASRV, LOGM, QDEL, UHT Downgrades: NSEC Initiations: VBIV Read on to get TheStreet Quant Ratings' detailed report:

QDEL Crosses Above Average Analyst Target

In recent trading, shares of Quidel Corp. have crossed above the average analyst 12-month target price of $22.00, changing hands for $22.11/share.

Quidel Becomes Oversold (QDEL)

Quidel Becomes Oversold (QDEL)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

QDEL Crosses Above Average Analyst Target

QDEL Crosses Above Average Analyst Target

In recent trading, shares of Quidel Corp. have crossed above the average analyst 12-month target price of $21.67, changing hands for $21.99/share.

Oversold Conditions For Quidel (QDEL)

Oversold Conditions For Quidel (QDEL)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Quidel Corp. Reaches Analyst Target Price

Quidel Corp. Reaches Analyst Target Price

In recent trading, shares of Quidel Corp. have crossed above the average analyst 12-month target price of $21.20, changing hands for $22.09/share.

Quidel Enters Oversold Territory (QDEL)

Quidel Enters Oversold Territory (QDEL)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Insider Trading Alert - QDEL, SPRT And SJW Traded By Insiders

Insider Trading Alert - QDEL, SPRT And SJW Traded By Insiders

Stocks with insider trader activity include QDEL, SPRT and SJW

Quidel Reaches Analyst Target Price

Quidel Reaches Analyst Target Price

In recent trading, shares of Quidel Corp. have crossed above the average analyst 12-month target price of $20.30, changing hands for $20.85/share.

Commit To Buy Quidel Corp. At $15, Earn 14.8% Annualized Using Options

Commit To Buy Quidel Corp. At $15, Earn 14.8% Annualized Using Options

Investors eyeing a purchase of Quidel Corp. stock, but tentative about paying the going market price of $17.46/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Quidel Enters Oversold Territory (QDEL)

Quidel Enters Oversold Territory (QDEL)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BMTC, BWINA, FLR, JOUT, K, LND, OXY, PACD, PCTY, RF, SFM, SMLP, SPGI, TAHO, TK, TRNO Downgrades: AHT, ALDW, ALJ, BELFA, BELFB, ERA, IRCP, IRIX, KATE, MTW, POPE, QDEL, QLGC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Quidel (QDEL) Shares Cross Above 200 DMA

Quidel (QDEL) Shares Cross Above 200 DMA

In trading on Monday, shares of Quidel Corp. crossed above their 200 day moving average of $19.36, changing hands as high as $19.60 per share.

TheStreet Quant Rating: C (Hold)